Document is current
Any future updates will be listed below
-
Authors
Garrido-Rodriguez, Martin https://orcid.org/0000-0003-4125-5643
Potel, Clement https://orcid.org/0000-0003-3655-4665
Burtscher, Mira Lea https://orcid.org/0000-0003-2628-0795
Becher, Isabelle https://orcid.org/0000-0001-7170-2235
Rodriguez-Mier, Pablo https://orcid.org/0000-0002-4938-4418
Müller-Dott, Sophia https://orcid.org/0000-0002-9710-1865
Savitski, Mikhail M. https://orcid.org/0000-0003-2011-9247
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 28 January 2026
First Online: 26 February 2026
Competing interests
: J.S.R. reports funding from GSK, Pfizer, and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer, Grunenthal, Moderna, and Owkin. The remaining authors declare no competing interests.
